April 30, 2021 Texas HIV Medication Advisory Committee
»
1. Call to Order and Welcome – Natalie Vanek, M.D., Committee Chair
1. Call to Order and Welcome – Natalie Vanek, M.D., Committee Chair
»
2. Logistical Announcement and Roll Call – Sallie Allen, Advisory Committee Coordination Office, HHSC
2. Logistical Announcement and Roll Call – Sallie Allen, Advisory Committee Coordination Office, HHSC
»
3. Review and Approval of January 29, 2021, Meeting Minutes (Vote Required) – Sallie Allen, Advisory Committee Coordination Office, HHSC
3. Review and Approval of January 29, 2021, Meeting Minutes (Vote Required) – Sallie Allen, Advisory Committee Coordination Office, HHSC
»
4. Department of State Health Services (DSHS) Updates - Manda Hall, M.D., Associate Commissioner of Community Health Improvement
4. Department of State Health Services (DSHS) Updates - Manda Hall, M.D., Associate Commissioner of Community Health Improvement
»
5. TB/HIV/STD Section Updates - Felipe Rocha, MSSW, Director TB/HIV/STD Section
5. TB/HIV/STD Section Updates - Felipe Rocha, MSSW, Director TB/HIV/STD Section
»
6. THMP Update - Rachel Sanor, THMP Manager » - a. THMP-MAC appointment progress b. THMP Enrollment c. Data Update on Demographics and Actuarial Projections d. Budget Mitigation Details
6. THMP Update - Rachel Sanor, THMP Manager »
a. THMP-MAC appointment progress b. THMP Enrollment
c. Data Update on Demographics and Actuarial Projections
d. Budget Mitigation Details
»
7. Presentation: Cabotegravir-Rilpivirine – Aimee Metzner, PharmD, AAHIVP, Viiv Healthcare
7. Presentation: Cabotegravir-Rilpivirine – Aimee Metzner, PharmD, AAHIVP, Viiv Healthcare
»
8. Sub-Committee Reports » - a. Formulary Sub-committee – Natalie Vanek, M.D. b. Governance/Data – Nancy Miertschin c. Eligibility – Frank Rosas
8. Sub-Committee Reports »
a. Formulary Sub-committee – Natalie Vanek, M.D. b. Governance/Data – Nancy Miertschin
c. Eligibility – Frank Rosas
»
9. Committee to vote on addition of Cabotegravir-Rilpivirine to THMP formulary (Vote Required)
9. Committee to vote on addition of Cabotegravir-Rilpivirine to THMP formulary (Vote Required)
»
10. Committee to vote on removal of certain medications from THMP formulary (Vote Required)
10. Committee to vote on removal of certain medications from THMP formulary (Vote Required)
»
11. Public Comment – Sallie Allen, Advisory Committee Coordination Office, HHSC
11. Public Comment – Sallie Allen, Advisory Committee Coordination Office, HHSC
»
Items 12 & 13 » - 12. Action items and agenda topics for next scheduled meeting July 30, 2021 – Natalie Vanek, M.D., Committee Chair 13. Adjourn – Natalie Vanek, M.D., Committee Chair
Items 12 & 13 »
12. Action items and agenda topics for next scheduled meeting July 30, 2021 – Natalie Vanek, M.D., Committee Chair 13. Adjourn – Natalie Vanek, M.D., Committee Chair
